Volume 15, Number 3—March 2009
Research
Coccidioidal Pneumonia, Phoenix, Arizona, USA, 2000–2004
Michelle M. Kim1, Janis E. Blair
, Elizabeth J. Carey, Qing Wu, and Jerry D. Smilack
, Elizabeth J. Carey, Qing Wu, and Jerry D. Smilack
Table 2
Characteristics of 35 CAP patients with or without coccidioidomycosis, Phoenix, Arizona, USA, 2000–2004*
| Characteristic | No. patients |
p value | |
|---|---|---|---|
| With coccidioidomycosis (n = 6†) | Without coccidioidomycosis (n = 29†) | ||
| Age, y, mean (range) | 59.2 (38.0–80.3) | 67.8 (61.8–73.8) | 0.25 |
| Male sex | 2 (33) | 13 (45) | 0.60 |
| White race |
6 (100) |
27 (93) |
0.50 |
| Location where evaluated | |||
| Hospital | 4 (67) | 20 (69) | 0.99 |
| Emergency department | 1 (17) | 3 (10) | 0.55 |
| Outpatient clinic |
1 (17) |
6 (21) |
0.99 |
| Signs and symptoms | |||
| Cough | 4 (67) | 27 (93) | 0.12 |
| Sputum production | 1 (17) | 16 (55) | 0.18 |
| Dyspnea | 6 (100) | 18 (62) | 0.21 |
| Fever | 5 (83) | 21 (72) | 0.99 |
| Chills | 3 (50) | 11 (38) | 0.98 |
| Night sweats | 2 (33) | 7 (24) | 0.99 |
| Rash |
3 (50) |
0 |
0.002 |
| Chest radiograph findings | |||
| Unilateral infiltrates | 5 (83) | 17 (59) | 0.50 |
| Bilateral infiltrates |
1 (17) |
8 (28) |
0.96 |
| Laboratory results | |||
| Leukocyte count, ×109 cells/L, mean (range) | 15.1‡ (9.1–21.2) | 11.0§ (9.1–12.9) | 0.07 |
| Absolute eosinophil count, ×109 cells/L, mean (range) |
2.96¶ (0.18–13) |
0.12# (0.0–0.2) |
0.32 |
| Empiric coccidioidal treatment prescribed after initial visit | 1 (17) | 1 (3) | 0.76 |
*CAP, community-acquired pneumonia. Values are no. (%) unless otherwise indicated.
†Unless otherwise indicated.
‡n = 6.
§n = 25.
¶n = 5.
#n = 22.
Page created: December 07, 2010
Page updated: December 07, 2010
Page reviewed: December 07, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.